Zacks: Analysts Expect Fate Therapeutics, Inc. (NASDAQ:FATE) Will Post Quarterly Sales of $7.07 …
Zacks: Analysts Expect Fate Therapeutics, Inc. (NASDAQ:FATE) Will Post Quarterly Sales of $7.07 … Wall Street analysts expect Fate Therapeutics, Inc. (NASDAQ:FATE) to report $7.07 million in sales for the current quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Fate Therapeutics’ earnings. The lowest sales estimate is $5.00 million and the […]
Read More